CARDINAL STOPS PRODUCTION OF DEFECTIVE DRUG PUMP AFTER FDA HAS U.S. MARSHALS CONFISCATE DEVICES

Cardinal Health announced that it stopped production of four Alaris drug infusion pumps. The announcement came after the FDA requested that U.S. marshals confiscate 1,300 devices out of the company's San Diego facility on Friday. The Alaris pumps, which are used to regulate the delivery of intravenous drugs to patients, have been linked to at least two deaths due to an oversensitive keypad.
News Inferno